CT Diseases Flashcards
slicc classification criteria for sle
more/= 4 criteria (at least 1 clinical and 1 lab) OR biopsy proven sle with positive ana/anti-dna
for long standing disease
2019 acr eular criteria
ana >/= 1:80 on HEp-2 cell or equivalent positive test + additive crtieria (>/= 10 points)
clinical domain in acr
SOAP BRAIN MD
serositits oral ulcer arthritic photosensitivity blood disorders renal disease ana immunophenomenon neurological disorders malar rish discoid rash
immunologic criteria in acr
ana, anti-dsdna, anti-smith, anti-i1rnp, anti-ro/ss-a, anti-la/ss-b, anti-histone, anti-phospholipid
diagnostics for sle
read
all patients with sle should be started on __
hydroxychloroquine
other treatments for sle
- corticosteroids
- iv methylprednisolone pulses
- oral prednisone
- plasmapheresis ivig
what is apas
autoantibody-mediated acquired thrombophilia characterized by recurrent arterial or venous thrombosis and/or pregnancy morbidity
criteria for apas
- venous/arterial thrombosis
- ob complications
- lupus anticoagulant
- anticardiolipin antibodies
- anti-b2 gylcoprotein -i antibodies
at least 1 clinical and 1 lab
treatment of apas
- first event: warfarin (2.5-3.5 inr)
- pregnant: low molecular weight heparin with aspirin
what is scleroderma
excessive production and accumulation of collagen (fibrosis) in skin and internal organs and injuries to small arteries
clinical presentation of scleroderma
- mucocutaneous telangiectasia
- raynaud’s digital ischemic ulcers
- pulmonary hypertension
- pericarditis
- skin induration
- calcinosis cutis
- hyperpigmentation
diagnosis of scleroderma
read
types of scleroderma
- limited cutaneous: indolent onset, limited, slow, anticentromere
- diffuse cutaneous: rapid onset, diffuse, antitopoisomerase I, anti rna polymerase III
hallmarks of scleroderma
- widespread capillary loss
- obliterative micoangiopathy
- combined with fibrosis in the skin and internal organs
diagnosis for scleroderma
- cbc
- cpk
- anas
- antiscl 70, anti centromere ab
- skin biopsy
treatment of scleroderma
- vascular therapy (arb, clopidogrel, prostacyclin, sildenafil, bosentan)
- immunosuppressive agents (methotrexate, aza, mycophenolate mofetil and cyclophosphamide)
- hydroxycholoroquine
- low dose prednisone
clinical presentation of sjorgen
- ocular symptoms
- dry mouth
- ear
- nose and paranasal sinuses
criteria for sjorgen syndrome
- histopath: focal lymphocytic sialoadenitis
- (+) anti-ro/ss-a
- sicca ocular score >/= 5
- schirmer test = 5 mm per 5 min
- unstimulated whole salivary flow =0.1 ml/min
+ = more/= 4 and symptoms of ocular/oral dryness
pathogenesis of sjorgen
- mutation of hla-dr and hla-dq
- environmental factors
- b-lymphocyte activation = exocrine gland dysfunction and destruction
diagnosis of sjorgen
- esr and cbc
- anas
- rheumatoid factor
- serum igg
- creatinine clearance